📰 Intima Bioscience News
Intima Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Intima Bioscience. Real-time updates on events, politics, business and more.
May 5, 2023
PRESS RELEASE Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio ... | May 5, 2023
March 7, 2023
Investegate announcements from MaxCyte, Inc., Preliminary Unaudited Q4 &FY 2022 Revenue Results
May 26, 2022
Transgene’s Combined General Meeting of May 25, 2022 Strasbourg, France, May 25, 2022, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonth...
May 25, 2022
Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard
May 10, 2022
MXCT earnings call for the period ending March 31, 2022.
March 31, 2022
The roles of Chairman and Chief Executive Officer will be separated. Dr. Riva proposed as new independent Director and non-executive Chairman of the Board. With more than 30 years of experience
March 22, 2022
GAITHERSBURG, Md., March 22, 2022 /PRNewswire/ -- MaxCyte, Inc., (NASDAQ: MXCT) (LSE: MXCT) is a leading commercial cell-engineering company focused on providing enabling platform technologies
February 6, 2022
Various pharmaceutical companies announced collaborations and licensing agreements from January 31 to February 1.
February 1, 2022
MaxCyte inks platform pact with Intima Bioscience
February 1, 2022
Various pharmaceutical companies announced collaborations and licensing agreements from January 31 to February 1.